
    
      A minimum of 3 patients will be entered into each dose-level cohort for 5 weeks. A
      dose-escalation schema will be employed in cohorts. The initial dose starts at 1 mg/kg on Day
      1 and 4 followed by 2mg/kg on Day 8. Dose escalation will occur on weeks 3-5 with a maximum
      weekly dose of 8 mg/kg. Patients who meet criteria of at least partial response will be
      eligible for additional 4 weekly doses at highest dose tolerated.
    
  